Labeler
NorthStar RxLLC NDC Codes
NorthStar RxLLC lists 301 finished drug products in the FDA NDC Directory under NDC labeler codes 16714, 72603.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Levothyroxine Sodium, Atomoxetine, Pregabalin, Dasatinib, Atorvastatin calcium, Doxepin Hydrochloride, Nebivolol, lurasidone hydrochloride, Lidocaine hydrochloride, Everolimus, Olmesartan medoxomil, Sacubitril and Valsartan, Midodrine Hydrochloride, Venlafaxine Hydrochloride, Irbesartan
- Active ingredients
- Levothyroxine sodium, Atomoxetine hydrochloride, Pregabalin, Dasatinib, Atorvastatin calcium trihydrate, Doxepin hydrochloride, Nebivolol hydrochloride, Lurasidone hydrochloride, Lidocaine hydrochloride anhydrous, Everolimus, Olmesartan medoxomil, Sacubitril
- NDC labeler codes
- 16714, 72603
- Strengths (from the 100 most recently listed products)
- Atorvastatin calcium trihydrate 10 mg/1; Lidocaine hydrochloride anhydrous 10 mg/mL; Lidocaine hydrochloride anhydrous 20 mg/mL; Bupivacaine hydrochloride 7.5 mg/mL; Ticagrelor 60 mg/1; Ticagrelor 90 mg/1; Olmesartan medoxomil 5 mg/1; Olmesartan medoxomil 20 mg/1; Olmesartan medoxomil 40 mg/1; Sacubitril 24 mg/1; Valsartan 26 mg/1; Sacubitril 49 mg/1; Valsartan 51 mg/1; Sacubitril 97 mg/1; Valsartan 103 mg/1; Midodrine hydrochloride 2.5 mg/1; Midodrine hydrochloride 5 mg/1; Midodrine hydrochloride 10 mg/1; Rivaroxaban 2.5 mg/1; Venlafaxine hydrochloride 37.5 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Capsule, Injection, Solution, Capsule, Extended release, Ointment, Solution, Suppository, Powder, For suspension, Tablet, Delayed release, Solution/ drops, Injection, Powder, Lyophilized, For solution
- Routes
- Oral, Infiltration, Perineural, Topical, Epidural, Retrobulbar, Rectal, Ophthalmic, Intravenous, Subcutaneous
- Drug classes (FDA established)
- Angiotensin 2 Receptor Blocker, l-Thyroxine, Kinase Inhibitor, Norepinephrine Reuptake Inhibitor, HMG-CoA Reductase Inhibitor, Amide Local Anesthetic, beta-Adrenergic Blocker, Tricyclic Antidepressant, Atypical Antipsychotic, Antiarrhythmic, mTOR Inhibitor Immunosuppressant, Neprilysin Inhibitor, alpha-Adrenergic Agonist, Serotonin and Norepinephrine Reuptake Inhibitor, Corticosteroid, Glinide, P2Y12 Platelet Inhibitor, Peroxisome Proliferator Receptor alpha Agonist, Osmotic Laxative, Factor Xa Inhibitor, Nonsteroidal Anti-inflammatory Drug, Direct Thrombin Inhibitor, Calculi Dissolution Agent, Phosphate Binder, Nucleoside Metabolic Inhibitor, Aminosalicylate, Proteasome Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 147 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 20 mg/1 | Tablet, Film coatedOral | 72603-283 | 72603-0283-0172603-0283-0272603-0283-03 | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 40 mg/1 | Tablet, Film coatedOral | 72603-284 | 72603-0284-0172603-0284-0272603-0284-03 | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 80 mg/1 | Tablet, Film coatedOral | 72603-285 | 72603-0285-0172603-0285-0272603-0285-03 | — |
| Pantoprazole Sodium | Pantoprazole sodium 40 mg/1 | Granule, Delayed releaseOral | 72603-317 | 72603-0317-30 | — |
| Pemetrexedpemetrexed disodium | Pemetrexed disodium hemipentahydrate 100 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 72603-325 | 72603-0325-01 | — |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 2.5 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | 72603-327 | 72603-0327-1072603-0327-25 | — |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 2.5 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | 72603-415 | 72603-0415-25 | — |
| Pemetrexedpemetrexed disodium | Pemetrexed disodium hemipentahydrate 500 mg/50mL | Injection, Powder, Lyophilized, For solutionIntravenous | 72603-425 | 72603-0425-01 | — |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 5 mg/mL | Injection, SolutionEpidural, Intracaudal, Perineural | 72603-506 | 72603-0506-1072603-0506-25 | — |
| Phenylephrine Hydrochloride | Phenylephrine hydrochloride 25 mg/mL | Solution/ dropsOphthalmic | 72603-520 | 72603-0520-0172603-0520-02 | — |
| Phenylephrine Hydrochloride | Phenylephrine hydrochloride 100 mg/mL | Solution/ dropsOphthalmic | 72603-530 | 72603-0530-01 | — |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 5 mg/mL | Injection, SolutionEpidural, Intracaudal, Perineural | 72603-602 | 72603-0602-25 | — |
| Vareniclinevarenicline tartrate | Varenicline tartrate .5 mg/1 | Tablet, Film coatedOral | 72603-476 | 72603-0476-01 | — |
| Vareniclinevarenicline tartrate | Varenicline tartrate 1 mg/1 | Tablet, Film coatedOral | 72603-477 | 72603-0477-01 | — |
| Vareniclinevarenicline tartrate | — | Kit | 72603-478 | 72603-0478-01 | — |
| Atropine Sulfate | Atropine sulfate 10 mg/mL | Solution/ dropsOphthalmic | 72603-264 | 72603-0264-0172603-0264-02 | — |
| nitroglycerin | Nitroglycerin .4 mg/1 | TabletSublingual | 72603-266 | 72603-0266-04 | — |
| Oxcarbazepine | Oxcarbazepine 300 mg/1 | Tablet, Film coatedOral | 72603-271 | 72603-0271-0172603-0271-02 | — |
| Oxcarbazepine | Oxcarbazepine 600 mg/1 | Tablet, Film coatedOral | 72603-272 | 72603-0272-0172603-0272-02 | — |
| Loteprednol Etabonate | Loteprednol etabonate 5 mg/mL | Suspension/ dropsOphthalmic | 72603-324 | 72603-0324-0172603-0324-0272603-0324-03 | — |
| Cyanocobalamin | Cyanocobalamin 1000 ug/mL | Injection, SolutionIntramuscular, Subcutaneous | 72603-650 | 72603-0650-25 | — |
| Rufinamide | Rufinamide 40 mg/mL | SuspensionOral | 72603-261 | 72603-0261-01 | — |
| Tobramycin | Tobramycin 300 mg/5mL | SolutionRespiratory (Inhalation) | 72603-430 | 72603-0430-56 | — |
| Tobramycin | Tobramycin 300 mg/4mL | SolutionRespiratory (Inhalation) | 72603-630 | 72603-0630-56 | — |
| Lacosamide | Lacosamide 10 mg/mL | InjectionIntravenous | 72603-263 | 72603-0263-02 | — |
| naloxone hydrochloride | Naloxone hydrochloride .4 mg/mL | Injection, SolutionIntramuscular, Intravenous, Subcutaneous | 72603-590 | 72603-0590-1072603-0590-25 | — |
| Formoterol fumarateformoterol fumarate dihydrate | Formoterol fumarate 20 ug/2mL | SolutionRespiratory (Inhalation) | 72603-620 | 72603-0620-3072603-0620-60 | — |
| arformoterol tartrate | Arformoterol tartrate 15 ug/2mL | SolutionRespiratory (Inhalation) | 72603-208 | 72603-0208-3072603-0208-60 | — |
| Ephedrine sulfate | Ephedrine sulfate 50 mg/mL | InjectionIntravenous | 72603-203 | 72603-0203-1072603-0203-25 | — |
| Zileuton | Zileuton 600 mg/1 | Tablet, Film coated, Extended releaseOral | 72603-246 | 72603-0246-01 | — |
| Enalapril maleate oral solutionenalapril maleate | Enalapril maleate 1 mg/mL | SolutionOral | 72603-247 | 72603-0247-01 | — |
| Atovaquone | Atovaquone 750 mg/5mL | SuspensionOral | 72603-248 | 72603-0248-01 | — |
| Oxcarbazepine | Oxcarbazepine 60 mg/mL | SuspensionOral | 72603-252 | 72603-0252-01 | — |
| Lidocaine Hydrochloride | Lidocaine hydrochloride 10 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | 72603-350 | 72603-0350-1072603-0350-25 | — |
| Lidocaine Hydrochloride | Lidocaine hydrochloride 20 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | 72603-410 | 72603-0410-25 | — |
| Fesoterodine Fumarate | Fesoterodine fumarate 4 mg/1 | Tablet, Film coated, Extended releaseOral | 72603-413 | 72603-0413-01 | — |
| Fesoterodine Fumarate | Fesoterodine fumarate 8 mg/1 | Tablet, Film coated, Extended releaseOral | 72603-414 | 72603-0414-01 | — |
| Aripiprazolearipiprazole oral | Aripiprazole 1 mg/mL | SolutionOral | 72603-445 | 72603-0445-01 | — |
| Lidocaine Hydrochloride | Lidocaine hydrochloride 20 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | 72603-505 | 72603-0505-1072603-0505-25 | — |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | Olmesartan medoxomil 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 72603-290 | 72603-0290-0172603-0290-02 | — |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 72603-291 | 72603-0291-0172603-0291-02 | — |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1 | Tablet, Film coatedOral | 72603-292 | 72603-0292-0172603-0292-02 | — |
| Valganciclovirvalganciclovir hydrochloride | Valganciclovir hydrochloride 50 mg/mL | Powder, For solutionOral | 72603-174 | 72603-0174-01 | — |
| Heparin Sodium | Heparin sodium 1000 [USP'U]/mL | InjectionIntravenous, Subcutaneous | 72603-234 | 72603-0234-25 | — |
| Heparin Sodium | Heparin sodium 5000 [USP'U]/mL | InjectionIntravenous, Subcutaneous | 72603-214 | 72603-0214-25 | — |
| Heparin Sodium | Heparin sodium 20000 [USP'U]/mL | InjectionIntravenous, Subcutaneous | 72603-224 | 72603-0224-25 | — |
| Heparin Sodium | Heparin sodium 1000 [USP'U]/mL | InjectionIntravenous, Subcutaneous | 72603-267 | 72603-0267-25 | — |
| Heparin Sodium | Heparin sodium 2000 [USP'U]/2mL | InjectionIntravenous, Subcutaneous | 72603-336 | 72603-0336-25 | — |
| Heparin Sodium | Heparin sodium 5000 [USP'U]/mL | InjectionIntravenous, Subcutaneous | 72603-412 | 72603-0412-25 | — |
| Heparin Sodium | Heparin sodium 10000 [USP'U]/mL | InjectionIntravenous, Subcutaneous | 72603-501 | 72603-0501-25 | — |
NorthStar RxLLC: common questions
- What is NorthStar RxLLC's NDC labeler code?
- 16714, 72603. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for NorthStar RxLLC?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.